Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. (ABOS) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
ABOS · net income · updated Jun 9, 2026
Core profitability metrics
ABOS · net income · margin · TTM · CAGRNet income was −$121.3M for FY2025 (fiscal year ending 2025-12-31), down 18.6% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · ABOS net income history · ABOS profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Acumen Pharmaceuticals, Inc. (ABOS) reported net income of −$121.3M for FY2025 (fiscal year ending 2025-12-31), down 18.6% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Acumen Pharmaceuticals, Inc. has not yet achieved annual profitability based on available data (7 fiscal years). The company has reported net losses across all available periods.
Acumen Pharmaceuticals, Inc.'s net profit margin was — for FY2025, based on the latest annual results.
Investors sometimes search for "Acumen Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from ABOS net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
ABOS net income · 4 questionsAcumen Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $121.3M for FY2025.
▸ Source: FMP /income-statement · GAAP · Acumen Pharmaceuticals, Inc. · Acumen Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026